CollPlant Biotechnologies Ltd. (CLGN) vs Xenetic Biosciences, Inc. (XBIO)
A side-by-side comparison of CollPlant Biotechnologies Ltd. and Xenetic Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLGN
CollPlant Biotechnologies Ltd.
$3.30HealthcareDelayed quote: Oct 6, 2026, 3:50 PM EDT
XBIO
Xenetic Biosciences, Inc.
$2.10HealthcareDelayed quote: Oct 6, 2026, 3:50 PM EDT
Total return — CLGN vs XBIO
growth of $100 · dividends reinvested · last 9yCLGN -96.2% (-30.5%/yr)XBIO -99.2% (-41.3%/yr)CLGN compounded faster over this window
CLGN XBIO
CLGN vs XBIO: by the numbers
- •XBIO is the larger company ($5M vs $4M market cap).
- •Both run net losses; XBIO's is the smaller (-75.90% vs -3934.91% net margin).
- •XBIO grew revenue faster over the past five years (34.31% vs -56.28% CAGR).
Metrics side by side
Valuation
| Metric | CLGN | XBIO |
|---|---|---|
| P/S ratio | 13.44 | 1.48 |
| P/B ratio | 1.45 | 0.79 |
Profitability
| Metric | CLGN | XBIO |
|---|---|---|
| Gross margin | 26.32% | 100.00% |
| Operating margin | -484.31% | -95.23% |
| Net margin | -3934.91% | -75.90% |
| ROE | -424.89% | -40.76% |
| ROIC | -221.32% | -43.50% |
Growth (annualized)
| Metric | CLGN | XBIO |
|---|---|---|
| Revenue CAGR (5Y) | -56.28% | 34.31% |
| Total return CAGR (5Y) | -53.69% | -34.54% |
Frequently asked
- Which has grown faster, CLGN or XBIO?
- Over the past five years, XBIO grew revenue faster — CLGN at a -56.28% CAGR versus XBIO at 34.31%.
- How have CLGN and XBIO total returns compared?
- Over the past 5 years, CLGN delivered -53.69% and XBIO delivered -34.54% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
CollPlant Biotechnologies ROEXenetic Biosciences ROECollPlant Biotechnologies operating marginXenetic Biosciences operating marginCollPlant Biotechnologies revenue growthXenetic Biosciences revenue growthCollPlant Biotechnologies free cash flowXenetic Biosciences free cash flow
CollPlant Biotechnologies & Xenetic Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.